Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Log ind
Få fuld adgang
Veltio Pharma AB
AB
Active
Org 5591612840
Uppsala
Bioteknisk forskning och utveckling
·
NACE 7210
Stiftet 2018 · 8 år gammel
1-4 ansatte
Overvåg
Del
Sverige
/
Virksomheder
/
Research and experimental development on natural sciences and engineering
/
Veltio Pharma AB
Overblik
Regnskaber
Personer & ejerskab
Relaterede virksomheder
Loading company…
Personer & ejerskab
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (2)
LS
Lisa Stina Katarina Lundgren
Chief Executive Officer
Chief Executive Officer
2025
EM
Eva Maria Andersson Dverstorp
Chief Auditor
Chief Auditor
2022
Tidligere (2)
JD
Jon Daniel Bergström
Chief Executive Officer
Chief Executive Officer
2024 – 2025
AM
Albert Mihranyan
Chief Executive Officer
Chief Executive Officer
2022 – 2024
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (6)
JD
Jon Daniel Bergström
Chairman
Chairman
2022
MO
Mats Olof Rickard Johnson
Board of Directors
Board of Directors
2022
ÅR
Åsa Rebecca Wallin
Board of Directors
Board of Directors
2026
JA
John Allan Asp
Board of Directors
Board of Directors
2022
AM
Albert Mihranyan
Board of Directors
Board of Directors
2022
AA
Ara Abrahamian
Board of Directors
Board of Directors
2026
Tidligere (1)
CA
Christel Anna Sofie Bergström
Board of Directors
Board of Directors
2022 – 2024
Aktionærer
Pr. seneste årsrapport
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Mere om Veltio Pharma AB
Overblik →
Hovedtal, risikovurdering og virksomhedsresumé
Regnskaber & nøgletal →
Omsætning, EBITDA, balance og 5-års udvikling
Relaterede virksomheder →
Koncernstruktur, moder- og datterselskabsnetværk